Skip to main content
Home > The Daily Extra > Financial News

Chronological Index of : Financial News

 Current Issue
  • FINANCIAL NEWS: Biogen authorizes $5B share buyback

    Biogen Inc. (NASDAQ:BIIB) said its board authorized a stock repurchase program for up to $5 billion of common stock, or about 13 million shares based on Thursday's closing price of $383.29. Biogen expects to complete …

    Published on 5/8/2015
  • FINANCIAL NEWS: aTyr, Collegium rise after IPOs

    aTyr Pharma Inc. (NASDAQ:LIFE) and Collegium Pharmaceutical Inc. (NASDAQ:COLL) each posted gains in their first day of trading Thursday after pricing IPOs.aTyr rose $0.95 to $14.95 after it raised $75 million through …

    Published on 5/7/2015
  • FINANCIAL NEWS: Spyryx raises $18M in series A

    Respiratory newco Spyryx Biosciences Inc. (Research Triangle Park, N.C.) raised $18 million in a series A round from Canaan Partners; Hatteras Venture Partners; and 5AM Ventures. The University of North Carolina spinout…

    Published on 5/7/2015
  • FINANCIAL NEWS: Verseon raises L65.8M in IPO

    Verseon Corp. (LSE:VSN) raised L65.8 million ($99.6 million) through the sale of 32.6 million shares at 202p in an IPO on the London Stock Exchange's AIM, making it the second largest biotech IPO on LSE after Circassia …

    Published on 5/7/2015
  • FINANCIAL NEWS: Adaptive Biotechnologies raises $195M series F

    Adaptive Biotechnologies Corp. (Seattle, Wash.) raised $195 million in a series F round, the third largest disclosed venture round for a biotech this year. Matrix Capital Management led Adaptive's round; other new …

    Published on 5/6/2015
  • FINANCIAL NEWS: IPO roundup: Adaptimmune, CoLucid, OpGen, HTG

    Cancer immunotherapy company Adaptimmune Therapeutics plc (NASDAQ:ADAP), migraine treatment developer CoLucid Pharmaceuticals Inc. (NASDAQ:CLCD), diagnostics company OpGen Inc. (NASDAQ:OPGN), and HTG Molecular …

    Published on 5/6/2015
  • FINANCIAL NEWS: Financial tracks

    Alternative asset management firm The Carlyle Group (NASDAQ:CG) named Jose Almeida an operating executive in its global heathcare group. Almeida was chairman, president and CEO of Covidien. Jason Kantor resigned as a …

    Published on 5/5/2015
  • FINANCIAL NEWS: Flagship partners with AstraZeneca, Nestle, Bayer

    Flagship Ventures announced partnerships with AstraZeneca plc (LSE:AZN; NYSE:AZN), the Nestle Health Science subsidiary of Nestle SA (SIX:NESN) and the Bayer CropScience subsidiary of Bayer AG (Xetra:BAYN) to develop …

    Published on 5/5/2015
  • FINANCIAL NEWS: Symbiomix caps series A, reports vaginosis data

    Symbiomix Therapeutics LLC raised $13 million in the third and final close of its series A round from OrbiMed, Fidelity BioSciences and HBM Partners. The company, which raised a total of $32.5 million in the round, also…

    Published on 5/5/2015
  • FINANCIAL NEWS: Financial tracks

    Lazard named Alexander Stern CEO of financial advisory and Matthieu Pigasse global head of M&A and sovereign advisory. Stern was COO at Lazard, and Pigasse was CEO of Lazard France.

    Published on 5/1/2015
  • FINANCIAL NEWS: Follow-on roundup: Inovio, Paratek, Advaxis

    Inovio Pharmaceuticals Inc. (NASDAQ:INO), Paratek Pharmaceuticals Inc. (NASDAQ:PRTK) and Advaxis Inc. (NASDAQ:ADXS) raised $199.3 million in follow-ons Thursday.Vaccine developer Inovio raised $76 million through the …

    Published on 4/30/2015
  • FINANCIAL NEWS: Mirna raises $41.8M in series D

    Mirna Therapeutics Inc. (Austin, Texas) raised $41.8 million in a series D round led by new investor Baxter Ventures. Other new investors included Eastern Capital; Sante Ventures; Morningside Ventures; Rock Springs …

    Published on 4/30/2015
  • FINANCIAL NEWS: MyoKardia raises $46M in series B

    Cardiovascular company MyoKardia Inc. (South San Francisco, Calif.) raised $46 million on Thursday in a series B financing from Casdin Capital; Cormorant Asset Management; Perceptive Life Sciences; an affiliate of Cowen…

    Published on 4/30/2015
  • FINANCIAL NEWS: Blueprint raises $146.6M in IPO

    Oncology company Blueprint Medicines Corp. (NASDAQ:BPMC) raised $146.6 million on Wednesday through the sale of 8.1 million shares at $18 in an IPO underwritten by Goldman Sachs; Cowen; JMP Securities; and Wedbush …

    Published on 4/29/2015
  • FINANCIAL NEWS: CRISPR Therapeutics pads coffers with $64M

    CRISPR Therapeutics AG (Basel, Switzerland) raised $64 million on Wednesday, including $35 million to top up its series A round and $29 million in a series B. In both rounds, a strategic investor led the financing -- SR…

    Published on 4/29/2015
  • FINANCIAL NEWS: GW raises $179.2M in follow-on

    GW Pharmaceuticals Inc. (LSE:GWP; NASDAQ:GWPH) raised $179.2 million through the sale of 1.6 million ADSs at $112 in a follow-on underwritten by Morgan Stanley; BofA Merrill Lynch; Cowen; and Piper Jaffray. GW proposed …

    Published on 4/29/2015
  • FINANCIAL NEWS: Viking gains after pricing IPO

    Metabolic and endocrine company Viking Therapeutics Inc. (NASDAQ:VKTX) gained $0.96 (12%) to $8.96 in its first day of trading after it raised $24 million through the sale of 3 million shares at $8 in an IPO …

    Published on 4/29/2015
  • FINANCIAL NEWS: Intarcia raises $225M in royalty deal

    Intarcia Therapeutics Inc. (Boston, Mass.) raised $225 million from undisclosed investors who received a 1.5% royalty on future global sales of diabetes compound ITCA 650. Morgan Stanley served as the placement agent.…

    Published on 4/28/2015
  • FINANCIAL NEWS: Biocartis gains in first trading day after IPO

    Molecular diagnostics company Biocartis Group N.V. (Euronext:BCART) gained EUR 1.50 (13%) to EUR 13 in its first day of trading Monday after it raised EUR 100 million ($107.8 million) in an IPO on Euronext Brussels last…

    Published on 4/27/2015
  • FINANCIAL NEWS: Financial tracks

    Investment bank Roth Capital Partners hired Michael Higgins as a senior research analyst for biotechnology and specialty pharmaceuticals. Higgins was a managing director and a senior specialty pharmaceuticals analyst at…

    Published on 4/27/2015
  • FINANCIAL NEWS: Biocartis prices EUR 100M IPO

    Molecular diagnostics company Biocartis Group N.V. (Euronext:BCART) raised EUR 100 million ($107.8 million) through the sale of 8.7 million shares at EUR 11.50 in an IPO on Euronext Brussels. Underwriters were KBC …

    Published on 4/24/2015
  • FINANCIAL NEWS: Pfenex raises $40.5 million in follow-on

    Pfenex Inc. (NYSE-M:PFNX) raised $40.5 million through the sale of 2.6 million shares at $15.50 in a follow-on underwritten by Barclays; Evercore; and William Blair. Existing stockholders also sold 3.4 million shares in…

    Published on 4/24/2015
  • FINANCIAL NEWS: Jounce raises $56M in series B round

    Cancer company Jounce Therapeutics Inc. (Cambridge, Mass.) raised $56 million in a series B round from Wellington Management, Redmile Group, Nextech Invest, Pharmstandard International, Cormorant Asset Management, Omega…

    Published on 4/23/2015
  • FINANCIAL NEWS: WuXi NextCODE invests $15M in DNAnexus

    The WuXi NextCODE Genomics subsidiary of WuXi PharmaTech Inc. (NYSE:WX) partnered with DNAnexus Inc. (Mountain View, Calif.) and invested $15 million in the genome informatics company. The companies intend to create new…

    Published on 4/23/2015
  • FINANCIAL NEWS: Oberland tops target with $425M royalty and credit fund

    Oberland Capital raised its first fund, a $425 million healthcare royalty and credit opportunities investment vehicle. The firm, which exceeded its $350 million target, plans to invest the Oberland Capital Healthcare …

    Published on 4/22/2015

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993